STOCK TITAN

[Form 4] Viatris Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Viatris director David S. Simmons reported the acquisition of 22,820 restricted stock units (RSUs) with a transaction date of 08/11/2025. Each RSU represents the right to receive one share of Viatris common stock at a $0 conversion price, and the award is scheduled to vest on March 6, 2026, at which point the RSUs convert into common shares.

The Form 4 shows this as an insider equity award reported by a single reporting person and executed under a power of attorney. The filing documents an equity grant/vesting schedule rather than a sale or cash purchase.

Il direttore di Viatris David S. Simmons ha dichiarato l'acquisizione di 22.820 unità di azioni vincolate (RSU) con data di negoziazione 08/11/2025. Ciascuna RSU conferisce il diritto a ricevere una azione ordinaria Viatris a un prezzo di conversione di $0, e l'assegnazione è prevista in vesting il 6 marzo 2026, data in cui le RSU si convertiranno in azioni ordinarie.

Il Modulo 4 indica che si tratta di una concessione azionaria da parte di un insider, segnalata da un'unica persona obbligata alla comunicazione e eseguita mediante procura. La pratica documenta una concessione e il relativo piano di vesting, non una vendita o un acquisto in contanti.

El director de Viatris David S. Simmons informó la adquisición de 22.820 unidades de acciones restringidas (RSU) con fecha de operación 08/11/2025. Cada RSU otorga el derecho a recibir una acción ordinaria de Viatris a un precio de conversión de $0, y la adjudicación está programada para consolidarse el 6 de marzo de 2026, momento en que las RSU se convertirán en acciones comunes.

El Formulario 4 muestra que se trata de una concesión de acciones por un insider, reportada por una sola persona informante y ejecutada mediante poder. La presentación documenta una concesión y un calendario de vesting de capital, no una venta ni una compra en efectivo.

Viatris 이사 David S. Simmons는 거래일이 08/11/202522,820개의 제한부 주식단위(RSU)를 취득했다고 보고했습니다. 각 RSU는 전환 가격 $0으로 Viatris 보통주 1주를 받을 권리를 의미하며, 수여분은 2026년 3월 6일에 베스팅되어 RSU가 보통주로 전환됩니다.

Form 4에는 단일 보고인이 보고한 내부자 지분 수여로 기재되어 있으며 위임장에 따라 실행된 것으로 나타납니다. 제출 서류는 매각이나 현금 매입이 아닌 지분 부여 및 베스팅 일정임을 문서화합니다.

Le directeur de Viatris David S. Simmons a déclaré l'acquisition de 22 820 unités d'actions restreintes (RSU) avec une date de transaction 08/11/2025. Chaque RSU donne droit à une action ordinaire de Viatris à un prix de conversion de 0 $, et l'attribution doit parvenir à maturité le 6 mars 2026, date à laquelle les RSU seront converties en actions ordinaires.

Le formulaire 4 indique qu'il s'agit d'une attribution d'actions par un initié, déclarée par une seule personne assujettie à l'obligation de déclaration et exécutée sous procuration. Le dossier documente une attribution et un calendrier de vesting d'actions, et non une vente ni un achat en espèces.

Viatris-Direktor David S. Simmons meldete den Erwerb von 22.820 Restricted Stock Units (RSUs) mit dem Transaktionsdatum 08/11/2025. Jede RSU berechtigt zum Erhalt einer Viatris-Stammaktie zu einem Umwandlungspreis von $0, und die Zuteilung soll am 6. März 2026 vesten, woraufhin die RSUs in Stammaktien umgewandelt werden.

Das Formular 4 weist dies als Insider-Aktienzuteilung aus, die von einer einzigen meldepflichtigen Person gemeldet und mittels Vollmacht ausgeführt wurde. Die Einreichung dokumentiert eine Aktiengewährung mit Vesting‑Plan und keinen Verkauf oder Barkauf.

Positive
  • 22,820 RSUs acquired, converting to common stock upon vesting
  • RSUs have a clear vesting date of March 6, 2026, providing transparent timing for potential share issuance
Negative
  • None.

Insights

TL;DR: A director received 22,820 RSUs; this is a compensation grant with limited immediate market impact.

The reported transaction is an equity award of 22,820 RSUs that convert one-for-one into common stock and vest on March 6, 2026. As this is a grant rather than a sale, it does not indicate insider selling pressure. The award increases potential future dilution when the RSUs vest and shares are issued, but the filing does not quantify current total outstanding shares or percentage dilution, so material impact cannot be assessed from this Form 4 alone.

TL;DR: Standard director RSU award disclosed; vesting date and direct ownership are clearly reported.

The disclosure identifies the reporting person as a director and records the award as directly beneficially owned following the reported transaction. The use of a power of attorney for filing is noted. This is a routine compensation disclosure that provides transparency about executive/director incentives and vesting timing, but the filing contains no indication of unusual governance events or material changes to control.

Il direttore di Viatris David S. Simmons ha dichiarato l'acquisizione di 22.820 unità di azioni vincolate (RSU) con data di negoziazione 08/11/2025. Ciascuna RSU conferisce il diritto a ricevere una azione ordinaria Viatris a un prezzo di conversione di $0, e l'assegnazione è prevista in vesting il 6 marzo 2026, data in cui le RSU si convertiranno in azioni ordinarie.

Il Modulo 4 indica che si tratta di una concessione azionaria da parte di un insider, segnalata da un'unica persona obbligata alla comunicazione e eseguita mediante procura. La pratica documenta una concessione e il relativo piano di vesting, non una vendita o un acquisto in contanti.

El director de Viatris David S. Simmons informó la adquisición de 22.820 unidades de acciones restringidas (RSU) con fecha de operación 08/11/2025. Cada RSU otorga el derecho a recibir una acción ordinaria de Viatris a un precio de conversión de $0, y la adjudicación está programada para consolidarse el 6 de marzo de 2026, momento en que las RSU se convertirán en acciones comunes.

El Formulario 4 muestra que se trata de una concesión de acciones por un insider, reportada por una sola persona informante y ejecutada mediante poder. La presentación documenta una concesión y un calendario de vesting de capital, no una venta ni una compra en efectivo.

Viatris 이사 David S. Simmons는 거래일이 08/11/202522,820개의 제한부 주식단위(RSU)를 취득했다고 보고했습니다. 각 RSU는 전환 가격 $0으로 Viatris 보통주 1주를 받을 권리를 의미하며, 수여분은 2026년 3월 6일에 베스팅되어 RSU가 보통주로 전환됩니다.

Form 4에는 단일 보고인이 보고한 내부자 지분 수여로 기재되어 있으며 위임장에 따라 실행된 것으로 나타납니다. 제출 서류는 매각이나 현금 매입이 아닌 지분 부여 및 베스팅 일정임을 문서화합니다.

Le directeur de Viatris David S. Simmons a déclaré l'acquisition de 22 820 unités d'actions restreintes (RSU) avec une date de transaction 08/11/2025. Chaque RSU donne droit à une action ordinaire de Viatris à un prix de conversion de 0 $, et l'attribution doit parvenir à maturité le 6 mars 2026, date à laquelle les RSU seront converties en actions ordinaires.

Le formulaire 4 indique qu'il s'agit d'une attribution d'actions par un initié, déclarée par une seule personne assujettie à l'obligation de déclaration et exécutée sous procuration. Le dossier documente une attribution et un calendrier de vesting d'actions, et non une vente ni un achat en espèces.

Viatris-Direktor David S. Simmons meldete den Erwerb von 22.820 Restricted Stock Units (RSUs) mit dem Transaktionsdatum 08/11/2025. Jede RSU berechtigt zum Erhalt einer Viatris-Stammaktie zu einem Umwandlungspreis von $0, und die Zuteilung soll am 6. März 2026 vesten, woraufhin die RSUs in Stammaktien umgewandelt werden.

Das Formular 4 weist dies als Insider-Aktienzuteilung aus, die von einer einzigen meldepflichtigen Person gemeldet und mittels Vollmacht ausgeführt wurde. Die Einreichung dokumentiert eine Aktiengewährung mit Vesting‑Plan und keinen Verkauf oder Barkauf.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SIMMONS DAVID S

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 08/11/2025 A 22,820 (1) (1) Common Stock 22,820 $0 22,820 D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026.
/s/ Kevin Macikowski, by power of attorney 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Viatris (VTRS)?

The reporting person is David S. Simmons, listed as a Director of Viatris Inc.

What securities and amount were reported on the Form 4 for VTRS?

The Form 4 reports acquisition of 22,820 Restricted Stock Units (RSUs), each representing one share of common stock.

When was the RSU transaction for VTRS reported and when do the RSUs vest?

The transaction date is 08/11/2025, and the RSUs are scheduled to vest on March 6, 2026.

How many shares will the RSUs convert into for VTRS?

Each RSU converts to one share, so the 22,820 RSUs will convert into 22,820 shares upon vesting.

Was the Form 4 filed jointly or by a single reporting person for VTRS?

The filing indicates it was submitted by one reporting person.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

12.14B
1.16B
0.26%
83.79%
3.25%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG